Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 07 01:57PM ET
Dollar change
Percentage change
IndexS&P 500 P/E29.65 EPS (ttm)2.32 Insider Own0.33% Shs Outstand352.90M Perf Week-0.10%
Market Cap24.22B Forward P/E18.82 EPS next Y3.66 Insider Trans-3.96% Shs Float350.27M Perf Month6.08%
Income827.80M PEG4.30 EPS next Q0.94 Inst Own97.60% Short Float / Ratio0.74% / 1.28 Perf Quarter-11.15%
Sales6.01B P/S4.03 EPS this Y7.68% Inst Trans-8.32% Short Interest2.60M Perf Half Y0.75%
Book/sh28.68 P/B2.40 EPS next Y7.96% ROA5.25% Target Price78.93 Perf Year3.58%
Cash/sh2.03 P/C33.91 EPS next 5Y6.90% ROE8.50% 52W Range62.70 - 79.90 Perf YTD7.25%
Dividend0.29 P/FCF19.20 EPS past 5Y-6.70% ROI6.77% 52W High-13.75% Beta1.14
Dividend %0.41% Quick Ratio0.79 Sales past 5Y1.73% Gross Margin58.87% 52W Low9.90% ATR1.11
Employees18000 Current Ratio1.02 Sales Q/Q2.64% Oper. Margin18.83% RSI (14)54.55 Volatility1.65% 1.35%
OptionableYes Debt/Eq0.29 EPS Q/Q15.38% Profit Margin13.77% Rel Volume0.34 Prev Close68.68
ShortableYes LT Debt/Eq0.21 EarningsOct 25 BMO Payout13.38% Avg Volume2.03M Price68.91
Recom1.90 SMA202.10% SMA50-0.93% SMA200-2.07% Volume490,326 Change0.33%
Date Action Analyst Rating Change Price Target Change
Oct-26-23Downgrade BofA Securities Buy → Neutral $70
Oct-05-23Initiated Exane BNP Paribas Outperform $91
Aug-07-23Initiated Seaport Research Partners Buy $92
Mar-27-23Upgrade Vertical Research Hold → Buy $74
Oct-12-22Upgrade Morgan Stanley Equal-Weight → Overweight $68 → $73
Mar-17-22Upgrade Argus Hold → Buy $68
Mar-14-22Upgrade Barclays Equal Weight → Overweight $75
Jan-03-22Downgrade Vertical Research Buy → Hold $82
Dec-17-21Initiated Mizuho Neutral $82
Nov-23-21Initiated Loop Capital Buy $90
Dec-05-23 08:00AM
Nov-24-23 11:31AM
Nov-02-23 04:15PM
Oct-31-23 04:15PM
Oct-27-23 02:29PM
11:09AM Loading…
Oct-26-23 11:09AM
Oct-25-23 10:17AM
Oct-23-23 06:53AM
06:00AM Loading…
Oct-19-23 09:00AM
Oct-18-23 10:01AM
Oct-03-23 02:37PM
Sep-29-23 05:30PM
Sep-19-23 10:30AM
Sep-12-23 11:00AM
Aug-31-23 12:16PM
Aug-30-23 04:15PM
Aug-29-23 01:02PM
Aug-24-23 05:27PM
Aug-18-23 11:39AM
Aug-17-23 05:15PM
Aug-03-23 03:52PM
07:30AM Loading…
Jul-27-23 07:30AM
Jul-26-23 08:05PM
Jul-20-23 02:30PM
Jul-06-23 01:13PM
Jun-29-23 04:15PM
Jun-28-23 10:24AM
Jun-27-23 10:07AM
Jun-22-23 08:00AM
Jun-05-23 04:15PM
Jun-02-23 01:38PM
Jun-01-23 06:39AM
May-26-23 12:35PM
May-25-23 09:50AM
May-22-23 06:55AM
May-15-23 01:38PM
May-12-23 07:00AM
May-08-23 03:15PM
May-03-23 12:53PM
May-01-23 09:18AM
Apr-27-23 08:57AM
Apr-26-23 07:43PM
Apr-06-23 04:15PM
Apr-05-23 08:55AM
Mar-29-23 04:15PM
Mar-14-23 04:23PM
Mar-10-23 04:15PM
Mar-07-23 07:04AM
Mar-03-23 11:30AM
Feb-24-23 02:05PM
Feb-13-23 09:50AM
Feb-10-23 12:31PM
Feb-09-23 07:27PM
Feb-02-23 03:50PM
Feb-01-23 05:54PM
Jan-27-23 11:51AM
Jan-24-23 04:15PM
Jan-19-23 07:53AM
Jan-10-23 02:09PM
Jan-05-23 04:15PM
Dec-22-22 05:51AM
Dec-05-22 09:00AM
Nov-24-22 03:48PM
Nov-22-22 06:36AM
Nov-16-22 08:47AM
Nov-08-22 05:45AM
Nov-03-22 04:15PM
Nov-02-22 07:56PM
Fortive Corp. engages in the design, development, manufacturing, and marketing of professional and engineered products, software, and services for a variety of end markets. It operates through the following segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides solutions to accelerate industrial and facility reliability and performance, as well as compliance and safety across a range of vertical end markets, including manufacturing, process industries, healthcare, utilities and power, communications, and electronics. The Precision Technologies segment supplies technologies such as electrical test and measurement instruments and services, energetic material devices, and a broad portfolio of sensor and control system solutions. The Advanced Healthcare Solutions segment serves healthcare customers with products and services for critical activities, including instrument and device reprocessing, instrument tracking, cell therapy equipment design and manufacturing, biomedical test tools, radiation safety monitoring, and asset management. The company was founded on November 10, 2015, and is headquartered in Everett, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LICO JAMES APresident and CEOJul 28Option Exercise27.26185,5405,057,820485,797Jul 31 05:47 PM
Murphy Patrick KPresident & CEO of AHSJul 28Option Exercise35.3821,793771,03682,509Jul 31 05:49 PM
McLaughlin Charles ESVP - Chief Financial OfficerJul 28Option Exercise27.2616,911460,994118,230Jul 31 05:51 PM
Mulhall Christopher M.VP - Chief Accounting OfficerJul 28Option Exercise29.634,436131,43610,549Jul 31 05:54 PM
Mulhall Christopher M.VP - Chief Accounting OfficerJul 28Option Exercise29.323,869113,43426,207Jul 31 05:54 PM
Murphy Patrick KPresident & CEO of AHSJul 28Sale76.5021,7931,667,16460,716Jul 31 05:49 PM
McLaughlin Charles ESVP - Chief Financial OfficerJul 28Sale76.6616,9111,296,397101,319Jul 31 05:51 PM
Mulhall Christopher M.VP - Chief Accounting OfficerJul 28Sale76.854,700361,19521,507Jul 31 05:54 PM
Mulhall Christopher M.VP - Chief Accounting OfficerJul 28Sale76.844,436340,8626,113Jul 31 05:54 PM
Walker Stacey A.SVP - Human ResourcesFeb 27Sale67.753,249220,12032,721Feb 27 06:51 PM
Walker Stacey A.SVP - Human ResourcesFeb 23Sale66.391,33688,69737,946Feb 23 08:33 PM
Schwarz Jonathan LSVP - Corporate DevelopmentFeb 21Option Exercise24.7514,026347,14457,000Feb 22 07:40 PM
Walker Stacey A.SVP - Human ResourcesFeb 17Sale68.672,063141,66640,150Feb 21 08:34 PM